ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.47
-0.67%
US Tech 100
18,142.40
-0.47%
S&P 500
5,267.84
-0.74%
US Dollar vs CAD
1.37359
0.32%
Bitcoin
66,771.23
-3.37%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Tourmaline Bio Inc (TRML)

  7. Tourmaline Bio Inc (TRML) News

TRML

Tourmaline Bio (TRML)

Tourmaline Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TRML
DateTimeSourceHeadlineSymbolCompany
05/23/20246:10AMGlobeNewswire Inc.Tourmaline Bio to Present at the Jefferies Global Healthcare ConferenceNASDAQ:TRMLTourmaline Bio Inc
05/16/20246:00AMGlobeNewswire Inc.Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY TrialNASDAQ:TRMLTourmaline Bio Inc
05/13/20243:18PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TRMLTourmaline Bio Inc
05/13/20246:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
05/13/20246:00AMGlobeNewswire Inc.Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:TRMLTourmaline Bio Inc
04/02/20246:00AMGlobeNewswire Inc.Avalo Therapeutics Appoints Biotech Leaders to Board of DirectorsNASDAQ:TRMLTourmaline Bio Inc
03/19/20246:00AMGlobeNewswire Inc.Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:TRMLTourmaline Bio Inc
02/27/20246:30AMGlobeNewswire Inc.Tourmaline Bio to Present at Upcoming Investor ConferencesNASDAQ:TRMLTourmaline Bio Inc
02/14/20248:08PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TRMLTourmaline Bio Inc
02/14/20247:51PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TRMLTourmaline Bio Inc
02/09/20243:22PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TRMLTourmaline Bio Inc
02/01/20247:00AMGlobeNewswire Inc.Tourmaline Bio to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology ConferenceNASDAQ:TRMLTourmaline Bio Inc
01/29/20243:01PMGlobeNewswire Inc.Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:TRMLTourmaline Bio Inc
01/26/20243:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
01/26/20243:08PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRMLTourmaline Bio Inc
01/25/20246:00AMGlobeNewswire Inc.Tourmaline Bio Announces Pricing of Public Offering of Common StockNASDAQ:TRMLTourmaline Bio Inc
01/24/20248:20PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRMLTourmaline Bio Inc
01/24/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
01/24/20243:05PMGlobeNewswire Inc.Tourmaline Bio Announces Proposed Public Offering of Common StockNASDAQ:TRMLTourmaline Bio Inc
01/08/20248:19AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
01/08/20246:00AMGlobeNewswire Inc.Tourmaline Bio Announces Expected Upcoming Key Milestones for the Clinical Development of TOUR006, a Long-Acting Subcutaneous Inhibitor of IL-6 with Best-in-Class Potential, in Thyroid Eye Disease (TED) and Atherosclerotic Cardiovascular Disease (ASCVD)NASDAQ:TRMLTourmaline Bio Inc
12/15/20233:00PMGlobeNewswire Inc.Tourmaline Bio added to the NASDAQ Biotechnology IndexNASDAQ:TRMLTourmaline Bio Inc
12/14/20237:27AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
12/14/20236:30AMGlobeNewswire Inc.Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the BoardNASDAQ:TRMLTourmaline Bio Inc
11/30/20237:25AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
11/01/20237:00AMGlobeNewswire Inc.Tourmaline Bio to Present at Upcoming Investor ConferencesNASDAQ:TRMLTourmaline Bio Inc
10/23/20237:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRMLTourmaline Bio Inc
10/23/20237:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRMLTourmaline Bio Inc
10/23/20237:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRMLTourmaline Bio Inc
10/23/20237:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRMLTourmaline Bio Inc
 Showing the most relevant articles for your search:NASDAQ:TRML

Your Recent History

EU
BMHA
BOURSOR MR HLFR 0.35% 24...
USOTC
DBLVF
Doubleview Gold (QB)
NASDAQ
FSZJX
Fidelity Advisor Sustain...
EU
CUSAA
Communaute Urbaine Stras...
COIN
AG10BTC
Agri10x Token
BIT
P1Z364
NLBNPIT1Z364 20351219 32...
COIN
RPTCETH
Reptilian Coin
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved